Literature DB >> 27925693

Identification of N-Arylated NH125 Analogues as Rapid Eradicating Agents against MRSA Persister Cells and Potent Biofilm Killers of Gram-Positive Pathogens.

Yasmeen Abouelhassan1, Akash Basak2, Hussain Yousaf1, Robert W Huigens1,2.   

Abstract

Bacterial biofilms housing dormant persister cells are innately tolerant to antibiotics and disinfectants, yet several membrane-active agents are known to eradicate tolerant bacterial cells. NH125, a membrane-active persister killer and starting point for development, led to the identification of two N-arylated analogues (1 and 2) that displayed improved biofilm eradication potencies compared to the parent compound and rapid persister-cell-killing activities in stationary cultures of methicillin-resistant Staphylococcus aureus (MRSA). We found 1 and 2 to be superior to other membrane-active agents in biofilm eradication assays, with 1 demonstrating minimum biofilm eradication concentrations (MBEC) of 23.5, 11.7, and 2.35 μm against MRSA, methicillin-resistant Staphylococcus epidermidis (MRSE), and vancomycin-resistant Enterococcus faecium (VRE) biofilms, respectively. We tested our panel of membrane-active agents against MRSA stationary cultures and found 1 to rapidly eradicate MRSA stationary cells by 4 log units (99.99 %) in 30 min. The potent biofilm eradication and rapid persister-cell-killing activities exhibited by N-arylated NH125 analogues could have significant impact in addressing biofilm-associated problems.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  MRSA; antibacterial agents; biofilms; drug-resistant bacteria; persister cells

Mesh:

Substances:

Year:  2017        PMID: 27925693     DOI: 10.1002/cbic.201600622

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Rapid kill assessment of an N-arylated NH125 analogue against drug-resistant microorganisms.

Authors:  Yasmeen Abouelhassan; Peilan Zhang; Yousong Ding; Robert W Huigens Iii
Journal:  Medchemcomm       Date:  2019-01-29       Impact factor: 3.597

Review 2.  Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.

Authors:  Robert W Huigens; Yasmeen Abouelhassan; Hongfen Yang
Journal:  Chembiochem       Date:  2019-10-02       Impact factor: 3.164

Review 3.  Strategies against methicillin-resistant Staphylococcus aureus persisters.

Authors:  Wooseong Kim; Gabriel L Hendricks; Katerina Tori; Beth B Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2018-03-23       Impact factor: 3.808

4.  Modular Synthetic Routes to Fluorine-Containing Halogenated Phenazine and Acridine Agents That Induce Rapid Iron Starvation in Methicillin-Resistant Staphylococcus aureus Biofilms.

Authors:  Ke Liu; Massimiliano Brivio; Tao Xiao; Verrill M Norwood; Young S Kim; Shouguang Jin; Antonio Papagni; Luca Vaghi; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2022-01-28       Impact factor: 5.084

Review 5.  Design and synthesis of hybrid compounds as novel drugs and medicines.

Authors:  Abdulaziz H Alkhzem; Timothy J Woodman; Ian S Blagbrough
Journal:  RSC Adv       Date:  2022-07-06       Impact factor: 4.036

6.  Efficacy data of halogenated phenazine and quinoline agents and an NH125 analogue to veterinary mycoplasmas.

Authors:  Marissa A Valentine-King; Katherine Cisneros; Margaret O James; Robert W Huigens; Mary B Brown
Journal:  BMC Vet Res       Date:  2020-04-06       Impact factor: 2.741

7.  Design Guidelines for Cationic Pillar[n]arenes that Prevent Biofilm Formation by Gram-Positive Pathogens.

Authors:  Dana Kaizerman-Kane; Maya Hadar; Roymon Joseph; Dana Logviniuk; Yossi Zafrani; Micha Fridman; Yoram Cohen
Journal:  ACS Infect Dis       Date:  2021-03-03       Impact factor: 5.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.